Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹4,456Cr
Rev Gr TTM
Revenue Growth TTM
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

CAPILLARY
VS
| Quarter | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | 15.8 |
| 136 | 161 | 159 |
Operating Profit Operating ProfitCr |
| 14.4 | 10.4 | 13.6 |
Other Income Other IncomeCr | 2 | 2 | 4 |
Interest Expense Interest ExpenseCr | 2 | 2 | 1 |
Depreciation DepreciationCr | 13 | 19 | 19 |
| 10 | 0 | 8 |
| -1 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | | | -22.1 |
| 6.5 | 0.2 | 4.3 |
| 1.4 | 0.0 | 1.1 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
|
| | 30.5 | 44.7 | 62.7 | 13.9 |
| 184 | 274 | 387 | 537 | 533 |
Operating Profit Operating ProfitCr |
| -7.4 | -22.9 | -19.9 | -2.3 | 10.9 |
Other Income Other IncomeCr | 10 | -15 | 22 | 10 | 14 |
Interest Expense Interest ExpenseCr | 2 | 9 | 11 | 18 | 8 |
Depreciation DepreciationCr | 18 | 29 | 40 | 56 | 60 |
| -23 | -103 | -93 | -75 | 11 |
| 0 | -2 | -5 | -7 | -3 |
|
| | -341.7 | 13.0 | 22.1 | 120.7 |
| -13.4 | -45.2 | -27.2 | -13.0 | 2.4 |
| -4.8 | -20.6 | -17.5 | -10.6 | 1.8 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 2 | 10 | 11 | 15 | 15 |
| 10 | 106 | 156 | 524 | 554 |
Current Liabilities Current LiabilitiesCr | 110 | 191 | 224 | 309 | 251 |
Non Current Liabilities Non Current LiabilitiesCr | 18 | 40 | 55 | 23 | 20 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 99 | 108 | 150 | 465 | 418 |
Non Current Assets Non Current AssetsCr | 41 | 239 | 296 | 406 | 420 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | 7 | -20 | 97 | -46 |
Investing Cash Flow Investing Cash FlowCr | -14 | -114 | -94 | -185 | 64 |
Financing Cash Flow Financing Cash FlowCr | 28 | 96 | 137 | 218 | 13 |
|
Free Cash Flow Free Cash FlowCr | 1 | -10 | -48 | 97 | -46 |
| -5.2 | -7.1 | 22.9 | -142.1 | -326.4 |
CFO To EBITDA CFO To EBITDA% | -9.4 | -14.0 | 31.2 | -821.0 | -71.1 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 0 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 1.5 | -1.1 | -1.6 | 8.8 | -1.8 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| -7.4 | -22.9 | -19.9 | -2.3 | 10.9 |
| -13.4 | -45.2 | -27.2 | -13.0 | 2.4 |
| -62.3 | -47.5 | -25.8 | -9.3 | 2.8 |
| -181.1 | -86.8 | -52.7 | -12.7 | 2.5 |
| -16.3 | -29.0 | -19.7 | -7.8 | 1.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
**Exchange Listing:** BSE / NSE (Listed November 2025) | **Sector:** Enterprise SaaS / Loyalty Tech
Capillary Technologies is a global leader in **AI-powered, cloud-native Software-as-a-Service (SaaS)** solutions. Founded in **2012**, the company provides an end-to-end technology stack that enables enterprise brands to manage complex loyalty programs and consumer engagement across **47 countries**. With a focus on high-value **Fortune 500** clients, Capillary has evolved into a "consolidation machine," utilizing strategic M&A to migrate legacy loyalty systems onto its high-margin, proprietary platform.
---
### **The "Single Source of Truth": Product Ecosystem & AI Architecture**
Capillary operates a unified, cross-channel suite designed to aggregate data from POS, e-commerce, mobile apps, and kiosks into a single customer view.
* **Core Platform Modules:**
* **Loyalty+:** The flagship engine for points, tiers, and program logic; recognized as a **"Leader"** in the **Forrester Wave Q4 2025**.
* **Engage+:** A multi-channel communication layer for personalized marketing automation.
* **Insights+:** A predictive analytics suite providing automated reporting and forecasting.
* **Rewards+:** A global fulfillment network offering a diverse catalog of consumer incentives.
* **Customer Data Platform (CDP):** The foundational data layer integrating disparate consumer touchpoints.
* **The aiRA Advantage:** The platform is powered by **aiRA (AI-powered Research Assistant)**, a proprietary framework that transitions the UI from complex dashboards to **agentic, conversational interfaces**. This allows enterprise users to launch campaigns and query deep analytics using **plain English**, effectively replacing the need for external analytics agencies.
* **Scale & Reliability:** The platform manages **1.8 billion (180 crore) consumer profiles** with a mission-critical **99.999% (five nines) uptime**.
---
### **Strategic Growth Levers & The M&A Playbook**
Capillary drives value through a disciplined "Land, Expand, and Migrate" strategy, targeting a **20%+ organic annual growth rate**.
| Growth Axis | Mechanism | Key Metric |
| :--- | :--- | :--- |
| **Organic Expansion** | Upselling modules and usage overages within the existing base. | **115% Organic NRR** |
| **Global Footprint** | Following MNC clients into new geographies (North America, EMEA, LATAM). | **59% Revenue from N. America** |
| **Inorganic Migration** | Acquiring legacy providers at **0.5x–1.5x revenue** and migrating clients to the cloud. | **Target 65% Gross Margin** |
**Recent Strategic Acquisitions:**
* **SessionM (Feb 2026):** Acquired from Mastercard for **$20M**; adds **$35M+** in revenue and strengthens the North American QSR and Retail footprint.
* **Kognitiv (May 2025):** A **CAD 23.44 million** deal that established a dominant presence in the Canadian market.
* **Brierley Integration:** Successfully sunset legacy Brierley platforms to improve operational leverage and cash flow.
---
### **Financial Performance & Operational Efficiency**
Following its **₹877.5 crore IPO** (including **₹345 crore** in fresh issue proceeds), the company has demonstrated significant margin expansion.
**9M FY26 Financial Highlights (Consolidated):**
* **Operating Revenue:** **₹543.25 crore** (Up **22%** YoY).
* **Adjusted EBITDA:** **₹71.20 crore** (Up **53%** YoY).
* **EBITDA Margin:** **13.1%** (Expansion of **260 bps**).
* **PAT Growth:** Increased **692%** to **₹9.02 crore**, driven by the migration of acquired customers to the core platform.
* **Annual Recurring Revenue (ARR):** **₹736.1 crore** ($115M+), representing **21%** growth since March 2025.
**Operating Leverage:**
Capillary exhibits strong scalability; in 9M FY26, revenue grew **22%** while headcount increased only **6%**. Approximately **60%** of costs are non-COGS (Technology, S&M, Corporate), allowing incremental revenue to flow directly to the bottom line.
---
### **Market Positioning & Client Portfolio**
Capillary targets "Enterprise Customers" (those contributing **>₹0.8 crore** in annual revenue).
* **Client Base:** **150+ total customers**, including **25 Fortune 50** companies and **2 of the Fortune 10**.
* **Key Verticals:** QSR, Airlines, Retail, CPG, and Healthcare.
* **Recent Wins:** Secured a **5-year, >$20M TCV** deal with a **Fortune 50 US Retailer** in March 2026.
* **FMCG Specialization:** Unique capability to provide interfaces for brands without direct retail presence, enabling them to engage end-consumers and channel partners (e.g., contractors or painters) directly.
---
### **Risk Assessment & Mitigation**
| Risk Factor | Context | Mitigation Strategy |
| :--- | :--- | :--- |
| **US Healthcare Volatility** | A Top 5 client is a large US payer facing profitability pressures. | Diversification into Retail/QSR; high integration "stickiness" makes displacement difficult. |
| **Gen-AI Disruption** | Potential for AI to commoditize traditional SaaS seats. | **Outcome-linked pricing** (per member/transaction) rather than seat-based pricing; focus on proprietary loyalty data. |
| **Inorganic Churn** | **96% Inorganic NRR** reflects planned attrition during migrations. | High **115% Organic NRR** more than offsets the churn from sunsetting legacy acquired assets. |
| **Integration Risk** | Rapid pace of M&A (SessionM, Kognitiv). | Proven playbook with **4-5 year cash payback** and **20%+ target ROIC**. |
---
### **Investment Summary**
Capillary Technologies represents a rare Indian-listed SaaS play with a dominant global footprint. By combining **high-margin recurring revenue (89.2% of total)** with a disciplined M&A strategy, the company is positioned to consolidate the fragmented global loyalty market. The successful integration of **aiRA** ensures the platform remains at the forefront of the AI transition, while its shift toward **Fortune 500** contracts provides long-term revenue visibility and defensive cash flows.